TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Bruix, J. AU - Reig, M. AU - Sherman, M. PY - 2016 DA - 2016// TI - Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2015.12.041 DO - 10.1053/j.gastro.2015.12.041 ID - Bruix2016 ER - TY - STD TI - Gerbes A, Zoulim F, Tilg H, et al. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut. 2017; https://doi.org/10.1136/gutjnl-2017-315068. ID - ref3 ER - TY - STD TI - Nault JC, Sutter O, Nahon P, et al. Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations. J Hepatol. 2017; https://doi.org/10.1016/j.jhep.2017.10.004. ID - ref4 ER - TY - STD TI - Sun Y, Guo W, Xu Y, et al. Circulating tumors cells from different vascular sites exhibit spatial heterogeneity in epithelial and mesenchymal composition and distinct clinical significance in hepatocellular carcinoma. Clin Cancer Res. 2017; https://doi.org/10.1158/1078-0432.CCR-17-1063. ID - ref5 ER - TY - STD TI - Ko E, Seo HW, Jung G. Telomere length and ROS levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma. Hepatology. 2017; https://doi.org/10.1002/hep.29604. ID - ref6 ER - TY - JOUR AU - Kolly, P. AU - Waidmann, O. AU - Vermehren, J. PY - 2017 DA - 2017// TI - Hepatocellular carcinoma recurrence after direct antiviral treatment: a European multicenter study JO - J Hepatol VL - 6 UR - https://doi.org/10.1016/j.jhep.2017.07.007 DO - 10.1016/j.jhep.2017.07.007 ID - Kolly2017 ER - TY - JOUR AU - Jiang, L. AU - Yan, Q. AU - Fang, S. PY - 2017 DA - 2017// TI - Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracelluar signal-regulated kinase signaling pathway JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29312 DO - 10.1002/hep.29312 ID - Jiang2017 ER - TY - JOUR AU - Koblansky, A. A. AU - Truax, A. D. AU - Liu, R. PY - 2016 DA - 2016// TI - The innate immune receptor NLRX1 functions as a tumor suppressor by reducing colon tumorigenesis and key tumor-promoting signals JO - Cell Rep VL - 14 UR - https://doi.org/10.1016/j.celrep.2016.02.064 DO - 10.1016/j.celrep.2016.02.064 ID - Koblansky2016 ER - TY - JOUR AU - Allen, I. C. AU - Moore, C. B. AU - Schneider, M. PY - 2011 DA - 2011// TI - NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways JO - Immunity VL - 34 UR - https://doi.org/10.1016/j.immuni.2011.03.026 DO - 10.1016/j.immuni.2011.03.026 ID - Allen2011 ER - TY - JOUR AU - Lei, Y. AU - Wen, H. AU - Yu, Y. PY - 2012 DA - 2012// TI - The mitochondrial proteins NLRX1 and TUFM form a complex that regulates type I interferon and autophagy JO - Immunity VL - 36 UR - https://doi.org/10.1016/j.immuni.2012.03.025 DO - 10.1016/j.immuni.2012.03.025 ID - Lei2012 ER - TY - JOUR AU - Eitas, T. K. AU - Chou, W. C. AU - Wen, H. PY - 2014 DA - 2014// TI - The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M113.533034 DO - 10.1074/jbc.M113.533034 ID - Eitas2014 ER - TY - JOUR AU - Mohan, M. AU - Kaushal, D. AU - Aye, P. P. PY - 2012 DA - 2012// TI - Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0034561 DO - 10.1371/journal.pone.0034561 ID - Mohan2012 ER - TY - JOUR AU - Lei, Y. AU - Kansy, B. A. AU - Li, J. PY - 2016 DA - 2016// TI - EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUMF protein complex JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2016.11 DO - 10.1038/onc.2016.11 ID - Lei2016 ER - TY - JOUR AU - Leber, A. AU - Hontecillas, R. AU - Tubau-Juni, N. PY - 2017 DA - 2017// TI - NLRX1 regulates effector and metabolic functions of CD4 (+) T cells JO - J Immunol VL - 198 UR - https://doi.org/10.4049/jimmunol.1601547 DO - 10.4049/jimmunol.1601547 ID - Leber2017 ER - TY - JOUR AU - Lupfer, C. AU - Kanneganti, T. D. PY - 2013 DA - 2013// TI - The expanding role of NLRs in antiviral immunity JO - Immunol Rev VL - 255 UR - https://doi.org/10.1111/imr.12089 DO - 10.1111/imr.12089 ID - Lupfer2013 ER - TY - JOUR AU - Feng, H. AU - Lenarcic, E. M. AU - Yamane, D. PY - 2017 DA - 2017// TI - NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR JO - Nat Immunol VL - 18 UR - https://doi.org/10.1038/ni.3853 DO - 10.1038/ni.3853 ID - Feng2017 ER - TY - JOUR AU - Xia, X. AU - Cui, J. AU - Wang, H. Y. PY - 2011 DA - 2011// TI - NLRX1 negatively regulates TLR-induced NF-kappaB signaling by targeting TRAF6 and IKK JO - Immunity VL - 34 UR - https://doi.org/10.1016/j.immuni.2011.02.022 DO - 10.1016/j.immuni.2011.02.022 ID - Xia2011 ER - TY - JOUR AU - Li, H. AU - Zhang, S. AU - Li, F. PY - 2016 DA - 2016// TI - NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation JO - Mol Immunol VL - 76 UR - https://doi.org/10.1016/j.molimm.2016.06.013 DO - 10.1016/j.molimm.2016.06.013 ID - Li2016 ER - TY - JOUR AU - Coutermarsh-Ott, S. AU - Simmons, A. AU - Capria, V. PY - 2016 DA - 2016// TI - NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-kappaB signaling JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8861 DO - 10.18632/oncotarget.8861 ID - Coutermarsh-Ott2016 ER - TY - JOUR AU - Tattoli, I. AU - Killackey, S. A. AU - Foerster, E. G. PY - 2016 DA - 2016// TI - NLRX1 acts as an epithelial-intrinsic tumor suppressor through the modulation of TNF-mediated proliferation JO - Cell Rep VL - 14 UR - https://doi.org/10.1016/j.celrep.2016.02.065 DO - 10.1016/j.celrep.2016.02.065 ID - Tattoli2016 ER - TY - JOUR AU - Wang, X. AU - Yang, C. AU - Liao, X. PY - 2017 DA - 2017// TI - NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma JO - Cancer Med VL - 6 UR - https://doi.org/10.1002/cam4.1202 DO - 10.1002/cam4.1202 ID - Wang2017 ER - TY - JOUR AU - Javachandran, A. AU - Dhungel, B. AU - Steel, J. C. PY - 2016 DA - 2016// TI - Epithelial-to mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma JO - J Hematol Oncol VL - 9 UR - https://doi.org/10.1186/s13045-016-0307-9 DO - 10.1186/s13045-016-0307-9 ID - Javachandran2016 ER - TY - JOUR AU - Ma, J. AU - Zeng, S. AU - Zhang, Y. PY - 2017 DA - 2017// TI - BMP4 promotes oxaliplatin resistence by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma JO - Cancer Lett VL - 411 UR - https://doi.org/10.1016/j.canlet.2017.09.041 DO - 10.1016/j.canlet.2017.09.041 ID - Ma2017 ER - TY - JOUR AU - Wu, H. AU - Tao, J. AU - Zhang, T. PY - 2017 DA - 2017// TI - MicroRNA-206 prevents the pathogenesis of hepatocellular carcinoma by modulating expression of met proto-oncogene and cyclin-dependent kinase 6 in mice JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29374 DO - 10.1002/hep.29374 ID - Wu2017 ER - TY - STD TI - Liang Y, Feng Y, Zong M, et al. Beta-catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic beta-catenin and MET. Hepatology. 2017; https://doi.org/10.1002/hep.29661. ID - ref26 ER - TY - STD TI - Kaji K, Nishimura N, Seki K, et al. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake. Int J Cancer. 2017; https://doi.org/10.1002/ijc.31193. ID - ref27 ER - TY - JOUR AU - Zhou, S. L. AU - Zhou, Z. J. AU - Hu, Z. Q. PY - 2015 DA - 2015// TI - CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3beta/Snail signaling JO - Cancer Lett VL - 358 UR - https://doi.org/10.1016/j.canlet.2014.11.044 DO - 10.1016/j.canlet.2014.11.044 ID - Zhou2015 ER - TY - JOUR AU - Zhang, Y. AU - Liu, Y. AU - Duan, J. PY - 2016 DA - 2016// TI - Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting P21 (Waf/Cip1) stabilization by activating the ERK1/2-MAPK pathway JO - Hepatology VL - 63 UR - https://doi.org/10.1002/hep.28395 DO - 10.1002/hep.28395 ID - Zhang2016 ER - TY - JOUR AU - Chai, Z. T. AU - Zhu, X. D. AU - Ao, J. Y. PY - 2015 DA - 2015// TI - microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/AKT pathway in hepatocellular carcinoma JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0150-4 DO - 10.1186/s13045-015-0150-4 ID - Chai2015 ER - TY - JOUR AU - Finn, R. S. AU - Zhu, A. X. AU - Farah, W. PY - 2018 DA - 2018// TI - Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysis JO - Heptology VL - 67 UR - https://doi.org/10.1002/hep.29486 DO - 10.1002/hep.29486 ID - Finn2018 ER - TY - JOUR AU - Desert, R. AU - Rohart, F. AU - Canal, F. PY - 2017 DA - 2017// TI - Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29254 DO - 10.1002/hep.29254 ID - Desert2017 ER - TY - STD TI - Peng JM, Bera R, Chiou CY, et al. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis. Hepatology. 2017; https://doi.org/10.1002/hep.29678. ID - ref33 ER - TY - STD TI - Wan S, Meyer AS, Weiler S, et al. Cytoplasmic localization of the cell polarity factor Scribble supports liver tumor formation and tumor cell invasiveness. Hepatology. 2017; https://doi.org/10.1002/hep.29669. ID - ref34 ER - TY - JOUR AU - Kobayashi, T. AU - Aikata, H. AU - Kobayashi, T. PY - 2017 DA - 2017// TI - Patients with early recurrence of hepatocellular carcinoma have poor prognosis JO - Hepatobiliary Pancrear Dis Int VL - 16 UR - https://doi.org/10.1016/S1499-3872(16)60181-9 DO - 10.1016/S1499-3872(16)60181-9 ID - Kobayashi2017 ER - TY - JOUR AU - Wan, Y. AU - Meng, F. AU - Wu, N. PY - 2017 DA - 2017// TI - Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells JO - Hepatology VL - 66 UR - https://doi.org/10.1002/hep.29138 DO - 10.1002/hep.29138 ID - Wan2017 ER - TY - JOUR AU - Li, D. AU - Fu, J. AU - Du, M. PY - 2016 DA - 2016// TI - Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization JO - Hepatology VL - 64 UR - https://doi.org/10.1002/hep.28637 DO - 10.1002/hep.28637 ID - Li2016 ER - TY - JOUR AU - Ally, A. AU - Balasundaram, M. AU - Carlsen, R. AU - Chuah, E. AU - Clarke, A. AU - Dhalla, N. AU - Holt, R. A. AU - Jones, S. J. AU - Lee, D. AU - Ma, Y. AU - Marra, M. A. PY - 2017 DA - 2017// TI - Comprehensive and integrative genomic characterization of hepatocellular carcinoma JO - Cell VL - 169 UR - https://doi.org/10.1016/j.cell.2017.05.046 DO - 10.1016/j.cell.2017.05.046 ID - Ally2017 ER -